EGOI-PCOS
  • About
    • The Group
      • Experts on Inositol
      • Experts on PCOS
    • Mission
    • Regulations and Statute
  • Publications
  • Activities
    • Fellowship
  • Affiliations
    • Support
  • Register
  • Login
Select Page

Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease

Jan 22, 2017

Authors: Antonio Simone Laganà, Paola Rossetti, Fabrizio Sapia, Benito Chiofalo, Massimo Buscema, Gaetano Valenti, Agnese Maria Chiara Rapisarda, Salvatore Giovanni Vitale

Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy

Jan 15, 2017

Authors: Pietro Cavalli and Elena Ronda

Combining treatment with myo-inositol and D -chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients

Nov 29, 2016

Authors: Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri

Physiological Role and Clinical Utility of Inositols in Polycystic Ovary Syndrome

Nov 3, 2016

Authors: Arturo Bevilacqua, Mariano Bizzarri

Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate

Oct 4, 2016

Authors: Mariano Bizzarri, Simona Dinicola, Arturo Bevilacqua, and Alessandra Cucina

Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome

Oct 3, 2016

Authors: Anshu Gupta, Daniela Jakubowicz, and John E. Nestler
« Older Entries
Next Entries »


Viale di Villa Massimo 37, 00161, Rome (Italy)
Email: office@egoipcos.com or info@egoipcos.com
P.IVA / VAT ID: 96501700585

Subscribe to our Newsletter

Terms of use

Privacy and Cookie Policy
Registration Privacy Policy

All Rights Reserved ©2020 The Experts Group on Inositols in Basic and Clinical Research (EGOI)
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}